Pyrrolidine → HCID 24857073, 화합물
반응식
CO[C:3](=[O:12])[C:4]1[CH:9]=[C:8](Br)[C:7](Cl)=[N:6][CH:5]=1.[NH:13]1[CH2:17][CH2:16][CH2:15][CH2:14]1.[F:18][C:19]1[CH:24]=[CH:23][C:22](B(O)O)=[CH:21][CH:20]=1.[NH2:28][C@@H:29]([CH2:34][OH:35])[CH2:30][CH:31]([CH3:33])[CH3:32]>>[F:18][C:19]1[CH:24]=[CH:23][C:22]([C:8]2[C:7]([N:13]3[CH2:17][CH2:16][CH2:15][CH2:14]3)=[N:6][CH:5]=[C:4]([CH:9]=2)[C:3]([NH:28][C@@H:29]([CH2:34][OH:35])[CH2:30][CH:31]([CH3:33])[CH3:32])=[O:12])=[CH:21][CH:20]=1참가 물질
5
실험 절차
The title compound was synthesized in analogy to the procedure described for the preparation of Example 43, using 5-bromo-6-chloro-nicotinic acid methyl ester, pyrrolidine (commercially available), 4-fluorophenyl-boronic acid (commercially available) and (R)-(−)-leucinol (commercially available) as starting materials. MS (ISP): 386.4 (M+H+).